BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26450780)

  • 1. Relations among depressive symptoms, electrocardiographic hypertrophy, and cardiac events in non-ST elevation acute coronary syndrome patients.
    Whang W; Davidson KW; Palmeri NO; Bhatt AB; Peacock J; Chaplin WF; Shimbo D; Edmondson DE
    Eur Heart J Acute Cardiovasc Care; 2016 Sep; 5(5):455-60. PubMed ID: 26450780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women.
    Westerhout CM; Lauer MS; James S; Fu Y; Wallentin L; Armstrong PW;
    Eur Heart J; 2007 Sep; 28(17):2064-9. PubMed ID: 17600040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrocardiographic left ventricular hypertrophy in patients with suspected acute cardiac ischemia--its influence on diagnosis, triage, and short-term prognosis: a multicenter study.
    Larsen GC; Griffith JL; Beshansky JR; D'Agostino RB; Selker HP
    J Gen Intern Med; 1994 Dec; 9(12):666-73. PubMed ID: 7876948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes.
    Savonitto S; Cohen MG; Politi A; Hudson MP; Kong DF; Huang Y; Pieper KS; Mauri F; Wagner GS; Califf RM; Topol EJ; Granger CB
    Eur Heart J; 2005 Oct; 26(20):2106-13. PubMed ID: 15987706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of electrocardiographic left ventricular hypertrophy and bundle branch block on the triage and outcome of ED patients with a suspected acute coronary syndrome: a multicenter study.
    Pope JH; Ruthazer R; Kontos MC; Beshansky JR; Griffith JL; Selker HP
    Am J Emerg Med; 2004 May; 22(3):156-63. PubMed ID: 15138949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction.
    Pilgrim T; Vranckx P; Valgimigli M; Stefanini GG; Piccolo R; Rat J; Rothenbühler M; Stortecky S; Räber L; Blöchlinger S; Hunziker L; Silber S; Jüni P; Serruys PW; Windecker S
    Am Heart J; 2016 May; 175():56-65. PubMed ID: 27179724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of electrocardiographic-determined left ventricular hypertrophy and associated ST-segment depression in patients with non-ST-elevation acute coronary syndromes.
    Ali S; Goodman SG; Yan RT; Budaj A; Fox KA; Gore JM; Brieger D; López-Sendón J; Langer A; van de Werf F; Steg PG; Yan AT
    Am Heart J; 2011 May; 161(5):878-85. PubMed ID: 21570517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of electrocardiographic interpretability on outcome in patients referred for stress testing.
    Bouzas-Mosquera A; Peteiro J; Broullón FJ; Méndez E; Barge-Caballero G; López-Pérez M; López-Sainz A; Alvarez-García N; Castro-Beiras A
    Eur J Clin Invest; 2012 May; 42(5):541-7. PubMed ID: 22050029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN; Devereux RB; Okin PM
    J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrocardiographic Left Ventricular Hypertrophy as a Predictor for Nonsignificant Coronary Artery Disease in Patients With Non-ST-Segment Elevation Myocardial Infarction.
    Misumida N; Kobayashi A; Saeed M; Fox JT; Kanei Y
    Angiology; 2016 Jan; 67(1):27-33. PubMed ID: 25735856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of electrocardiographic and echocardiographic left ventricular hypertrophy to predict adverse events in patients with a first non-ST-elevation acute myocardial infarction.
    Barrabés JA; Figueras J; Cortadellas J; Lidón RM; Ibars S
    Am J Cardiol; 2009 Feb; 103(4):455-60. PubMed ID: 19195501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
    Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW
    Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ST-segment elevation on intracoronary electrocardiogram after percutaneous coronary intervention is associated with worse outcome in patients with non-ST-segment elevation myocardial infarction.
    Hishikari K; Kakuta T; Lee T; Murai T; Yonetsu T; Isobe M
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):E113-21. PubMed ID: 26152334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
    JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
    Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
    Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in ST segment on ECG of hypertensive patients].
    Riabykina GV; Liutikova LN; Saidova MA; Botvina IuV; Kozhemiakina ESh; Shchedrina EV; Sobolev AV
    Ter Arkh; 2008; 80(5):67-73. PubMed ID: 18590119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome.
    Taglieri N; Marzocchi A; Saia F; Marrozzini C; Palmerini T; Ortolani P; Cinti L; Rosmini S; Vagnarelli F; Alessi L; Villani C; Scaramuzzino G; Gallelli I; Melandri G; Branzi A; Rapezzi C
    Am J Cardiol; 2011 Jul; 108(1):21-8. PubMed ID: 21529728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
    Palmieri V; Okin PM; de Simone G; Bella JN; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocardiographic classification of acute coronary syndromes: a review by a committee of the International Society for Holter and Non-Invasive Electrocardiology.
    Nikus K; Pahlm O; Wagner G; Birnbaum Y; Cinca J; Clemmensen P; Eskola M; Fiol M; Goldwasser D; Gorgels A; Sclarovsky S; Stern S; Wellens H; Zareba W; de Luna AB
    J Electrocardiol; 2010; 43(2):91-103. PubMed ID: 19913800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.